GMRE — Global Medical REIT Cashflow Statement
0.000.00%
Last trade - 00:00- $531.91m
- $1.16bn
- $141.05m
- 55
- 63
- 43
- 53
Annual cashflow statement for Global Medical REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9.59 | -2.5 | 18.3 | 20 | 21.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5.98 | 8.35 | 7.66 | 1.65 | -5.56 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.77 | -7.65 | -3.82 | -1.74 | -5.69 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 36.4 | 34.5 | 69 | 76.5 | 68.4 |
| Capital Expenditures | -258 | -224 | -202 | -156 | -10 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.016 | 0.208 | 7 | 18.9 | 77.7 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -258 | -224 | -195 | -137 | 67.6 |
| Financing Cash Flow Items | -1.33 | -2.83 | -8.89 | -5.19 | 7.15 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 224 | 193 | 128 | 62.4 | -144 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.34 | 3.57 | 2.01 | 1.7 | -7.73 |